Resources Investment Advisors, Llc. Gilead Sciences, Inc. Call Options Transaction History

Resources Investment Advisors, Llc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $28,936 - $33,600	-400 Reduced 0.4%	100,000 $7.69 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $25,052 - $32,088	400 Added 0.4%	100,400 $7.51 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $6.1 Million - $6.71 Million	99,000 Added 9900.0%	100,000 $6.5 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $62,510 - $69,000	1,000 New	1,000 $63,000

1,953

993M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.